Gene therapy in the post-gelsinger era

JONA's Healthcare Law, Ethics, and Regulation

Volumn 4, Issue 4, 2002, Pages 104-110

  Smith, Lynn ^a   Byers, Jacqueline Fowler ^a  

^a UNIVERSITY OF CENTRAL FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; BIOMEDICAL AND BEHAVIORAL RESEARCH; ETHICS; GENE THERAPY; GENETICS AND REPRODUCTION; GOVERNMENT REGULATION; HOMICIDE; HUMAN; HUMAN EXPERIMENT; INFORMED CONSENT; LEGAL APPROACH; LEGAL ASPECT; PROFESSIONAL STANDARD; UNITED STATES;

BIOMEDICAL AND BEHAVIORAL RESEARCH; GENETICS AND REPRODUCTION; LEGAL APPROACH;

ADOLESCENT; ETHICS COMMITTEES, RESEARCH; GENE THERAPY; GOVERNMENT REGULATION; HOMICIDE; HUMANS; INFORMED CONSENT; PHILADELPHIA; THERAPEUTIC HUMAN EXPERIMENTATION; UNITED STATES;

EID: 0036885931     PISSN: 15209229     EISSN: 1530073X     Source Type: Journal    
DOI: 10.1097/00128488-200212000-00004     Document Type: Article

References (21)

1. Nelson D, Weiss R. Penn researchers sued in gene therapy death: teen’s parents also name ethicist as a defendant. Washington Post. 2000; September 19: A03.
2. Friedmann T. Principles for human gene therapy studies. Science. 2000; 287: 2163-2165.
3. Maloney DM. Protection of Human Research Subjects: A Practical Guide to Federal Laws and Regulations. New York: Plenum Press; 1984.
4. Woodward B. Challenges to human subject protections in US medical research. JAMA. 1999; 282(20): 1947-1952.
5. Rainsbury J. Biotechnology on the RAC-FDA/NIH regulation of human gene therapy. Food Drug Law J. 2000; 55: 575-599.
6. Marshall E. Gene therapy on trial. Science. 2000; 288: 951-957.
7. Kuszler P. Financing clinical research and experimental therapies: payment due, but from whom? DePaul J Health Care Law. 2000.
8. Meyers AS. A look at informed consent; a lot of rules, too many exceptions. Washington Post. 2000; January 30: B03.
9. Barnes M, Florencio P. IRBs tend to grow short of needed skills. Nat Law J. 2000; September 4: B9.
10. Behrman R, Kliegman R, Arvin A. Nelson Textbook of Pediatrics. 15th ed. Philadelphia: W.B. Saunders Company; 1996.
11. Weiss R, Nelson D. Victims’ dad faults gene therapy team; researchers misled family of teen about risks, senate oversight panel is told. Washington Post. 2000; February 3: A02.
12. Weiss R, Nelson D. Gene researchers apologize for lapses in teen’s fatal treatment. Washington Post. 1999; December 10: A06.
13. Nelson D, Weiss R. Gene researchers admit mistakes, deny liability. Washington Post. 2000; February 15: A03.
14. Nelson D, Weiss R. Penn ends gene trials on humans. Washington Post. 2000; May 25: A01.
15. Silberner J. A gene therapy death. Hastings Center Rep. 2000; 30(2): 6.
16. Nelson D, Weiss R. Hasty decisions in the race to a cure? Gene therapy study proceeded despite safety, ethics concerns. Washington Post. 1999; November 21: A01.
17. Nelson D, Weiss R. Earlier gene therapy deaths not reported; NIH was unaware of ‘adverse events.' Washington Post. 2000; January 31: A01.
18. Weiss R. NIH panel backs easing of gene therapy rules; reporting of ‘adverse events’ at issue. Washington Post. 2000; June 30: A29.
19. Smaglik P. NIH tightens up monitoring of gene-therapy mishaps. Nature. 2000; 404(2): 5-6.
20. Weiss R, Nelson D. Penn settles gene therapy suit; university pays undisclosed sum to the family of teen who died. Washington Post. 2000; November 4: A04.
21. Collins R. Death highlights gap in bioethics; case brings pressure for tougher codes on those performing medical research. Fulton County Daily Report. 2000; October 7.